These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27367272)

  • 1. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.
    Peng HY; Cheng YC; Hsu YM; Wu GH; Kuo CC; Liou JP; Chang JY; Jin SL; Shiah SG
    PLoS One; 2016; 11(7):e0158440. PubMed ID: 27367272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway.
    Oh HN; Seo JH; Lee MH; Kim C; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Shim JH; Chae JI
    J Cell Biochem; 2018 Dec; 119(12):10118-10130. PubMed ID: 30129052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mRNA through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR.
    Cheng YC; Liou JP; Kuo CC; Lai WY; Shih KH; Chang CY; Pan WY; Tseng JT; Chang JY
    Mol Cancer Ther; 2013 Jul; 12(7):1202-12. PubMed ID: 23619299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity instead of immunotoxicity of OTA is induced through DNMT1-dependent activation of JAK2/STAT3 signaling pathway by targeting SOCS3.
    Gan F; Zhou X; Zhou Y; Hou L; Chen X; Pan C; Huang K
    Arch Toxicol; 2019 Apr; 93(4):1067-1082. PubMed ID: 30923867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Tsai IT; Kuo CC; Liou JP; Chang JY
    J Biomed Sci; 2018 Mar; 25(1):28. PubMed ID: 29592811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
    Sen B; Saigal B; Parikh N; Gallick G; Johnson FM
    Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    Int Immunopharmacol; 2017 Aug; 49():203-211. PubMed ID: 28601022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
    Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
    Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway.
    Liu JR; Wu WJ; Liu SX; Zuo LF; Wang Y; Yang JZ; Nan YM
    Pathol Res Pract; 2015 Jun; 211(6):426-34. PubMed ID: 25724470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells.
    Ji Y; Wang Z; Li Z; Li K; Le X; Zhang T
    Cell Physiol Biochem; 2012; 29(5-6):863-74. PubMed ID: 22613986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3 pathway.
    Duan WN; Xia ZY; Liu M; Sun Q; Lei SQ; Wu XJ; Meng QT; Leng Y
    Mol Med Rep; 2017 Sep; 16(3):2668-2674. PubMed ID: 28713982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.
    Attia YM; Tawfiq RA; Ali AA; Elmazar MM
    Sci Rep; 2017 Oct; 7(1):12502. PubMed ID: 28970500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.